Pricing of pharmaceuticals is becoming a major challenge for health systems

13 January 2020 - Manufacturers using their market power to maximise profits results in prices that are unjustifiable and unaffordable. ...

Read more →

Defining the concept of fair pricing for medicines

13 January 2020 - Suerie Moon and colleagues consider what makes a fair price for both buyers and sellers. ...

Read more →

The Tories must learn from the Orkambi victory and keep drug-pricing off the table

12 January 2020 - To match its rhetoric on the NHS, the government has to legally commit to preventing drug-pricing being ...

Read more →

Biotech companies defend prices of one-off gene therapy

9 December 2019 - Latest treatments with price tags as high as $2 million require new financing models. ...

Read more →

Is it time to look beyond price with biosimilars?

5 December 2019 - While there is no question that falling prices that come with competition are cause for optimism in ...

Read more →

NHS and drug prices could be included in US-UK trade deal, leaked documents suggest

27 November 2019 - The NHS and drug patents have been part of ongoing post-Brexit trade negotiations between the US ...

Read more →

Labour will exclude the NHS and medicines from trade deals with the US

17 November 2019 - Donald Trump wants the big US pharmaceutical companies to get its hands on our public services – ...

Read more →

Paying £500 million more a week for drugs post-Brexit is based on a fairly extreme scenario

7 November 2019 - The UK could pay £500 million more per week for drugs following a post-Brexit trade deal with ...

Read more →

Brexit: what it could mean for drug prices

5 November 2019 - Trading away the UK’s rights to drive down drug prices could cost the NHS half a ...

Read more →

Corbyn accuses Tories of planning deal to hike drug prices with Trump as election looms

5 November 2019 - Drug prices have become an issue in the UK’s general election, after Labour leader Jeremy Corbyn ...

Read more →

NHS bill for US drugs 'could soar under post-Brexit trade deal'

28 October 2019 - Dispatches investigation finds 'drug pricing' has been discussed in six initial meetings between trade officials from the ...

Read more →

UK officials discussed NHS at ‘secret’ meetings with US drug companies as part of trade talks

29 October 2019 - Envoys sidestep ban on discussing drug prices by referring to controversial subject ‘valuing innovation’. ...

Read more →

Drug pricing: Could Labour’s “radical” plan work?

4 October 2019 - A necessary reform or a threat to research? ...

Read more →

Drug firms 'colluded' to overcharge NHS by up to 1,800%

3 October 2019 - Three drug manufactures broke competition law by colluding to illegally boost the price of a vital ...

Read more →

Industry shoots down Labour's plans to tackle 'extortionate' drug prices

26 September 2019 - Labour's promise to “take on pharmaceutical companies” which “deny life-saving and life-changing medicines to ill patients ...

Read more →